{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:55:53Z","timestamp":1778730953313,"version":"3.51.4"},"reference-count":16,"publisher":"FapUNIFESP (SciELO)","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"abstract":"<jats:p>Abstract Ischemic stroke is a common cause of death. The role of statins in the secondary prevention of the chronic ischemic stroke phase has been established. However, evidence regarding their efficacy in this phase is limited and contradictory.  Objective:  To evaluate the association between statin use and mortality risk during the acute phase of ischemic stroke in patients admitted to an intensive care unit.  Methods:  This was an observational and prospective study of ischemic stroke patients aged \u226518, admitted to an intensive care unit. Medications used during the first 7 days after the ictus, as well as medications used previously, were recorded. The primary outcome was all-cause mortality during the first 7 days.  Results:  We screened 212 patients and included 97 patients with ischemic stroke in the study period. The mortality rate among patients who used statins during the acute IS phase [14% (9\/63)] was significantly lower than that among patients who did not use statins [41% (14\/34); p=0.007]. This was confirmed in logistical regression with an 0.19 Odds Ratio - OR [p=0.018; 95% confidence interval - 95%CI 0.05-0.75]. Patients who died were older, had a higher incidence of acute myocardial infarction, higher scores on the NIHSS and lower systolic blood pressure. Statins and angiotensin converting enzyme inhibitors were used more frequently among survivors. These associations persisted even after adjustment for confounding variables.  Conclusion:  Statins and angiotensin converting enzyme inhibitors use during hospitalization were independently associated to a lower rate of all-cause mortality in the first 7 days of intensive care unit admission.<\/jats:p>","DOI":"10.1590\/0004-282x20190172","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T01:45:11Z","timestamp":1584409511000},"page":"158-162","source":"Crossref","is-referenced-by-count":4,"title":["Association between statin use and mortality risks during the acute phase of ischemic stroke in patients admitted to an intensive care unit"],"prefix":"10.1590","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8818-6924","authenticated-orcid":false,"given":"Natalia Eduarda","family":"FURLAN","sequence":"first","affiliation":[{"name":"Universidade do Estado de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2227-7505","authenticated-orcid":false,"given":"Juli Thomaz de","family":"SOUZA","sequence":"additional","affiliation":[{"name":"Universidade do Estado de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0607-8189","authenticated-orcid":false,"given":"Silm\u00e9ia Garcia Zanati","family":"BAZAN","sequence":"additional","affiliation":[{"name":"Universidade do Estado de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9787-4393","authenticated-orcid":false,"given":"Roberto Jorge da Silva","family":"FRANCO","sequence":"additional","affiliation":[{"name":"Universidade do Estado de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6914-7225","authenticated-orcid":false,"given":"Gustavo Jos\u00e9","family":"LUVIZUTTO","sequence":"additional","affiliation":[{"name":"Universidade Federal do Tri\u00e2ngulo Mineiro,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5763-0829","authenticated-orcid":false,"given":"Ana L\u00facia","family":"GUT","sequence":"additional","affiliation":[{"name":"Universidade do Estado de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1057-5089","authenticated-orcid":false,"given":"Gabriel Pinheiro","family":"MODOLO","sequence":"additional","affiliation":[{"name":"Universidade do Estado de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7299-5612","authenticated-orcid":false,"given":"Fernanda Cristina","family":"WINCKLER","sequence":"additional","affiliation":[{"name":"Universidade do Estado de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1435-7994","authenticated-orcid":false,"given":"Luis Cuadrado","family":"MARTIN","sequence":"additional","affiliation":[{"name":"Universidade do Estado de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3872-308X","authenticated-orcid":false,"given":"Rodrigo","family":"BAZAN","sequence":"additional","affiliation":[{"name":"Universidade do Estado de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2020,3]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ncl.2008.07.003","article-title":"Epidemiology of Ischemic and Hemorrhagic Stroke: Incidence, Prevalence, Mortality, and Risk Factors","volume":"26","author":"Grysiewicz RA","year":"2008","journal-title":"Neurol Clin"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1590\/S0066-782X2012005000041","article-title":"An\u00e1lise da tend\u00eancia da mortalidade por acidente vascular cerebral no Brasil no s\u00e9culo XXI","volume":"98","author":"Garritano CR","year":"2012","journal-title":"Arq Bras Cardiol"},{"key":"ref3","series-title":"Sistema de Informa\u00e7\u00e3o Hospitalar do Sistema \u00danico de Sa\u00fade (SIH\/SUS)","year":"2009"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5935\/abc.2013S010","article-title":"V Diretriz Brasileira de Dislipidemias e Preven\u00e7\u00e3o da Aterosclerose","volume":"101","author":"Xavier HT","year":"2013","journal-title":"Arq Bras Cardiol"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco P","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"ref6","first-page":"261","article-title":"Pre-stroke use of statins on stroke outcome: a meta-analysis of observational studies","volume":"111","author":"Cordenier A","year":"2011","journal-title":"Acta Neurol Belg"},{"issue":"9","key":"ref7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1212\/01.wnl.0000269789.09277.47","article-title":"Statin treatment withdrawal in ischemic stroke: a controlled randomized study","volume":"69","author":"Blanco M","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000228709","article-title":"High-dose lovastatin for acute ischemic stroke: results of the phase I dose escalation neuroprotection with statin therapy for acute recovery trial (NeuSTART)","volume":"28","author":"Elkind MSV","year":"2009","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/01.STR.32.4.980","article-title":"Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice","volume":"32","author":"Amin-Hanjani S","year":"2001","journal-title":"Stroke"},{"issue":"1-2","key":"ref10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0006-8993(02)02649-5","article-title":"Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice","volume":"942","author":"Laufs U","year":"2002","journal-title":"Brain Res"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.10555","article-title":"Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke","volume":"53","author":"Chen J","year":"2003","journal-title":"Ann Neurol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1331.2007.02015.x","article-title":"Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial","volume":"15","author":"Montaner J","year":"2008","journal-title":"Eur J Neurol"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1590\/S0080-62342011000500008","article-title":"Estado neurol\u00f3gico e cogni\u00e7\u00e3o de pacientes p\u00f3s-acidente vascular cerebral","volume":"45","author":"Costa FA","year":"2011","journal-title":"Rev Esc Enferm USP"},{"issue":"3","key":"ref14","first-page":"219","article-title":"Tromb\u00f3lise no AVCI agudo em um Hospital da Rede P\u00fablica: a experi\u00eancia do Hospital de Cl\u00ednicas de Porto Alegre","volume":"15","author":"Martins SC","year":"2007","journal-title":"Rev Neurocienc"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1590\/S0004-27301999000400004","article-title":"III Consenso brasileiro de hipertens\u00e3o arterial","volume":"43","year":"1999","journal-title":"Arq Bras Endocrinol Metab"},{"issue":"3A","key":"ref16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1590\/S0004-282X2005000400032","article-title":"Abordagem da doen\u00e7a carot\u00eddea na fase aguda do acidente vascular cerebral: opini\u00e3o nacional","volume":"63","author":"Gagliardi RJ","year":"2005","journal-title":"Arq Neuropsiquiatr"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v78n3\/1678-4227-anp-0004-282x20190172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T16:52:14Z","timestamp":1611420734000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2020000300158&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["S0004-282X2020000300158"],"URL":"https:\/\/doi.org\/10.1590\/0004-282x20190172","relation":{},"ISSN":["1678-4227","0004-282X"],"issn-type":[{"value":"1678-4227","type":"electronic"},{"value":"0004-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}